Skip to main content
Episurf logo

Episurf — Investor Relations & Filings

Ticker · EPIS ISIN · SE0003491562 LEI · 549300GORBCSMHZB2J75 ST Manufacturing
Open in API
Filings indexed 873 across all filing types
Latest filing 2022-04-04 AGM Information
Country SE Sweden
Listing ST EPIS

About Episurf

https://episurf.com/

Episurf is a medical device company that develops and commercializes patient-specific solutions for treating painful joint injuries. The company's core technology utilizes 3D imaging to create personalized orthopedic implants and surgical instruments tailored to each patient's unique anatomy and cartilage defect. Its primary product line, the Episealer® system, provides minimally invasive implants for treating cartilage and underlying bone lesions in the knee and ankle joints. The objective of this individualized approach is to repair the joint, alleviate pain, and restore function, offering a treatment option for patients, often middle-aged, who are not yet candidates for total joint replacement surgery.

Recent filings

Filing Released Lang Actions
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)
AGM Information Classification · 1% confidence The document is titled "KOMMUNIKÉ FRÅN ÅRSSTÄMMA I EPISURF MEDICAL AB (PUBL)" which translates to "COMMUNIQUÉ FROM THE ANNUAL GENERAL MEETING IN EPISURF MEDICAL AB (PUBL)". It details the resolutions passed at the AGM held on April 4, 2022, including the approval of financial statements, election of board members, approval of remuneration, and decisions regarding incentive programs and changes to the articles of association. This content directly relates to the proceedings and outcomes of an Annual General Meeting. Therefore, the appropriate classification is AGM-R (AGM Information).
2022-04-04 Swedish
New Chinese patent approval for Episurf Medical
Regulatory Filings Classification · 1% confidence The document is a very short announcement (1766 characters) detailing the receipt of a Chinese patent approval for a specific technology ('System and method for optimising an implant position in an anatomical joint'). It includes contact information, a brief 'About' section, and a concluding statement that the information is made public pursuant to the EU Market Abuse Regulation. This type of specific, non-financial, non-shareholder-meeting-related regulatory update that doesn't fit into the other specific categories (like ER, 10-K, DIV, etc.) is best classified as a general Regulatory Filing or announcement. Since 'Regulatory Filings (RNS)' is defined as the fallback for miscellaneous filings that do not neatly fit elsewhere, and this is a specific regulatory event announcement (patent approval), RNS is the most appropriate code.
2022-03-15 English
Nytt patentbeviljande i Kina för Episurf Medical
Regulatory Filings Classification · 1% confidence The document is a short announcement in Swedish regarding a new patent grant in China for Episurf Medical. It details the patent subject matter and includes standard contact and 'About Us' sections. Crucially, the final paragraph states: "Denna information är sådan information som Episurf Medical AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning" (This information is information that Episurf Medical AB is obliged to disclose under the EU Market Abuse Regulation). This indicates a mandatory regulatory disclosure that is not a standard periodic report (like 10-K or IR) or a specific event filing (like AGM or DIV). Since it is a general regulatory announcement concerning intellectual property/business development that doesn't fit the specific categories like LTR (Legal Proceedings) or CAP (Financing), the most appropriate fallback category is Regulatory Filings (RNS). The document length is short (1754 chars), but it is the primary disclosure, not an announcement *of* another report, so RPA is less suitable than RNS for this type of mandatory regulatory news.
2022-03-15 Swedish
Nytt patentbeviljande i USA för Episurf Medical
Legal Proceedings Report Classification · 1% confidence The document is a short announcement in Swedish regarding a new patent grant in the USA ('Nytt patentbeviljande i USA'). It details the patent subject ('Guide tool for cartilage repair') and includes a quote from the COO. Crucially, the final paragraph states: 'Denna information är sådan information som Episurf Medical AB är skyldigt att offentliggöra enligt EU:s marknadsmissbruksförordning' (This information is such information that Episurf Medical AB is obliged to disclose pursuant to the EU's Market Abuse Regulation). This strongly suggests a mandatory regulatory disclosure that doesn't fit the specific categories like ER, 10-K, or DIV. Since it is a general regulatory announcement concerning intellectual property/business development and doesn't fit the other specific categories (like M&A, Financing, or Director Dealing), the most appropriate fallback category is Regulatory Filings (RNS). The document length is very short (1725 chars), supporting the idea that it is a brief announcement rather than a comprehensive report.
2022-03-09 Swedish
New US patent approval for Episurf Medical
Regulatory Filings Classification · 1% confidence The document announces a specific corporate event: the receipt of a US patent approval (Notice of Allowance from USPTO) related to the company's technology. This is a material event announcement. It is not an Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or a formal shareholder communication like a Proxy Statement (PSI) or AGM material. It is a specific operational/legal update regarding intellectual property. Since there is no specific category for 'Patent Approval Announcement', and it is a regulatory-style disclosure mandated under EU Market Abuse Regulation (MAR), it falls best under the general 'Regulatory Filings' category (RNS) as a miscellaneous, material regulatory disclosure that doesn't fit the other specific codes (like DIRS, LTR, or CAP). The document length is short (1748 chars), but it is the primary content, not an announcement *of* another report.
2022-03-09 English
Annual Report (ESEF) 2021
Annual Report (ESEF) Classification · 1% confidence FY 2021
2022-03-07 Swedish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.